Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/08/2003WO2003038062A2 Generation of use of tc1 and tc2 cells
05/08/2003WO2003038061A2 Ehrlichia disulfide bond formation proteins and uses thereof
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038047A2 Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037927A1 Novel protein, its dna and use thereof
05/08/2003WO2003037921A1 Immunointeractive molecules and uses thereof
05/08/2003WO2003037919A2 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037372A1 Method for restoring disordered physiological processes and a medicament for carrying out said method
05/08/2003WO2003037371A2 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
05/08/2003WO2003037370A2 Anthrax antigenic compositions
05/08/2003WO2003037367A2 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037275A2 Compositions and methods for viral delivery
05/08/2003WO2003037265A2 Method of treating viral infections
05/08/2003WO2003037264A2 Therapeutic anti-hiv (vpr) compounds
05/08/2003WO2003037261A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003005955A3 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
05/08/2003WO2002102305B1 Adjuvant composition for mucosal and injection delivered vaccines
05/08/2003WO2002100891A3 Proteins derived from non-typable haemophilus influenzae (nthi) strain
05/08/2003WO2002098368A3 Mutant forms of cholera holotoxin as an adjuvant
05/08/2003WO2002095023A3 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
05/08/2003WO2002087494A3 Novel vaccine
05/08/2003WO2002085283A3 Vaccine against tuberculosis
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002069985A3 Immune response potentiation
05/08/2003WO2002038612A3 Canine and feline tumour-associated antigen 5t4
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003WO1999009179A3 Antigen constructs useful in the detection and differentiation of antibodies to hiv
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
05/08/2003US20030088082 Nucleotide sequences coding polypeptide for use in veterinary medicine
05/08/2003US20030088074 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
05/08/2003US20030088062 Polypeptide for use as an antiproliferative agent in the treatment of cell proliferative disorders
05/08/2003US20030088060 Human ion channels
05/08/2003US20030087872 Fucosidase 32616 is differentially expressed in tumor and/or angiogenic tissue samples as compared to normal tissue samples
05/08/2003US20030087846 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
05/08/2003US20030087824 Determination metastasis using protein
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087421 Lawsonia intracellularis
05/08/2003US20030087417 Newcastle disease virus infectious clones, vaccines and diagnostic assays
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087393 Endostatin for use in the treatment of cancer and tumor metastasis
05/08/2003US20030087383 Transformed Pichia expresing the pertactin antigen
05/08/2003US20030087375 Sperm specific proteins
05/08/2003US20030087372 Methods of culturing animal cells and polypeptide production in animal cells
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
05/08/2003US20030087295 Methods and compositions for the treatment and diagnosis of pain disorders using 9805
05/08/2003US20030087266 IGs as modifiers of the p53 pathway and methods of use
05/08/2003US20030087249 93870, a human G-protein coupled receptor and uses therefor
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
05/08/2003US20030086947 For diagnosis and prevention of ungulate diseases caused by treponeme spirochete bacteria
05/08/2003US20030086946 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
05/08/2003US20030086945 Porcine reproductive and respiratory syndrome virus and methods of use
05/08/2003US20030086942 Inhibition of nucleocytoplasmic transport by vesicular stomatitis virus M protein-like polypeptides
05/08/2003US20030086941 For diagnosing and therapy of gastrin-dependent tumor
05/08/2003US20030086940 For prophylaxis or therapy of rejection of xenotransplants are
05/08/2003US20030086939 Methods to improve immunogenicity of antigens and specificity of antibodies
05/08/2003US20030086938 Effecting presentation to the animal's immune system of an immunogenically effective amount of at least one analogue of autologous beta amyloid (A beta ) protein or autologous amyloid precursor
05/08/2003US20030086935 p53 vaccine
05/08/2003US20030086934 Basal cell markers in breast cancer and uses thereof
05/08/2003US20030086932 For use in downmodulation or upmodulation of the immune response; for preparing an allogeinc cell for transplantation
05/08/2003US20030086930 Administering CTLA-4 (cytotoxic T lymphocyte antigen-4) antibodies for therapy of cancer
05/08/2003US20030086929 Administering inhibitor of ATP synthase activity in a pharmaceutically effective amount for therapy and prophylaxis of prostate cancer
05/08/2003US20030086928 For use in therapy
05/08/2003US20030086926 Skeletal cell model to screen anti-diabetic compounds
05/08/2003US20030086925 Treatment of autoimmune diseases
05/08/2003US20030086921 For therapy and prophylaxis of allergic conditions, autoimmune diseases and inflammatory diseases
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086911 Methods and compositions for the stimulation of human immunodeficiency virus-specific cytotoxic T lymphocytes employing autologous antigen-peripheral blood mononuclear cells
05/08/2003US20030086905 In utero oral nucleic acid immunization
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003DE20219829U1 Vaccine formulation against bacterial, viral, mycotic, prion or parasitic infections, includes a combination of at least two paraben esters and 2-phenoxyethanol as preservative
05/08/2003CA2466156A1 Ehrlichia disulfide bond formation proteins and uses thereof
05/08/2003CA2465639A1 Tumor antigen
05/08/2003CA2465402A1 Anthrax antigenic compositions
05/08/2003CA2465367A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2465037A1 Genetic vaccine against human immunodeficiency virus
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462652A1 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003CA2458850A1 Fibrin nanoparticles and uses thereof
05/07/2003EP1308514A2 ICAM-4 Materials and Methods
05/07/2003EP1308462A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
05/07/2003EP1308172A1 Method for protein-preserving purification of contaminated biological liquids
1 ... 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 ... 1823